インテグラーゼ阻害剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Integrase Inhibitors Market Insights, Forecast to 2028

• レポートコード：QY2207E10391 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のインテグラーゼ阻害剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインテグラーゼ阻害剤の世界市場のxxx％を占める「ラルテグラビル」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「クリニック」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のインテグラーゼ阻害剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのインテグラーゼ阻害剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのインテグラーゼ阻害剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 インテグラーゼ阻害剤のグローバル主要メーカーには、Merck、GlaxoSmithKline、Hetero Drugs、Mylan、Aurobindo Pharma、Cipla、Laurus Labs、Gilead Sciences、Micro Labsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 インテグラーゼ阻害剤市場は、種類と用途によって区分されます。世界のインテグラーゼ阻害剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ラルテグラビル、ドルテグラビル、エルビテグラビル、ビクテグラビル 【用途別セグメント】 クリニック、病院 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - インテグラーゼ阻害剤製品概要 - 種類別市場（ラルテグラビル、ドルテグラビル、エルビテグラビル、ビクテグラビル） - 用途別市場（クリニック、病院） - 調査の目的 ・エグゼクティブサマリー - 世界のインテグラーゼ阻害剤販売量予測2017-2028 - 世界のインテグラーゼ阻害剤売上予測2017-2028 - インテグラーゼ阻害剤の地域別販売量 - インテグラーゼ阻害剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別インテグラーゼ阻害剤販売量 - 主要メーカー別インテグラーゼ阻害剤売上 - 主要メーカー別インテグラーゼ阻害剤価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ラルテグラビル、ドルテグラビル、エルビテグラビル、ビクテグラビル） - インテグラーゼ阻害剤の種類別販売量 - インテグラーゼ阻害剤の種類別売上 - インテグラーゼ阻害剤の種類別価格 ・用途別市場規模（クリニック、病院） - インテグラーゼ阻害剤の用途別販売量 - インテグラーゼ阻害剤の用途別売上 - インテグラーゼ阻害剤の用途別価格 ・北米市場 - 北米のインテグラーゼ阻害剤市場規模（種類別、用途別） - 主要国別のインテグラーゼ阻害剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのインテグラーゼ阻害剤市場規模（種類別、用途別） - 主要国別のインテグラーゼ阻害剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のインテグラーゼ阻害剤市場規模（種類別、用途別） - 主要国別のインテグラーゼ阻害剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のインテグラーゼ阻害剤市場規模（種類別、用途別） - 主要国別のインテグラーゼ阻害剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのインテグラーゼ阻害剤市場規模（種類別、用途別） - 主要国別のインテグラーゼ阻害剤市場規模（トルコ、サウジアラビア） ・企業情報 Merck、GlaxoSmithKline、Hetero Drugs、Mylan、Aurobindo Pharma、Cipla、Laurus Labs、Gilead Sciences、Micro Labs ・産業チェーン及び販売チャネル分析 - インテグラーゼ阻害剤の産業チェーン分析 - インテグラーゼ阻害剤の原材料 - インテグラーゼ阻害剤の生産プロセス - インテグラーゼ阻害剤の販売及びマーケティング - インテグラーゼ阻害剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - インテグラーゼ阻害剤の産業動向 - インテグラーゼ阻害剤のマーケットドライバー - インテグラーゼ阻害剤の課題 - インテグラーゼ阻害剤の阻害要因 ・主な調査結果

Integrase inhibitors (INIs) are the most new class of antiretroviral medications to be approved to treat HIV infection. They are quickly becoming standard treatments for both HIV naive and substantially pre-treated patients.
Market Analysis and Insights: Global Integrase Inhibitors Market
Due to the COVID-19 pandemic, the global Integrase Inhibitors market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Raltegravir accounting for % of the Integrase Inhibitors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Clinic segment is altered to an % CAGR throughout this forecast period.
China Integrase Inhibitors market size is valued at US$ million in 2021, while the US and Europe Integrase Inhibitors are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Integrase Inhibitors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Integrase Inhibitors include Merck, GlaxoSmithKline, Hetero Drugs, Mylan, Aurobindo Pharma, Cipla, Laurus Labs, Gilead Sciences and Micro Labs. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Integrase Inhibitors Scope and Segment
Integrase Inhibitors market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Integrase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Raltegravir
Dolutegravir
Elvitegravir
Bictegravir
Segment by Application
Clinic
Hospital
By Company
Merck
GlaxoSmithKline
Hetero Drugs
Mylan
Aurobindo Pharma
Cipla
Laurus Labs
Gilead Sciences
Micro Labs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Integrase Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global Integrase Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Raltegravir
1.2.3 Dolutegravir
1.2.4 Elvitegravir
1.2.5 Bictegravir
1.3 Market by Application
1.3.1 Global Integrase Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Integrase Inhibitors Sales Estimates and Forecasts 2017-2028
2.2 Global Integrase Inhibitors Revenue Estimates and Forecasts 2017-2028
2.3 Global Integrase Inhibitors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Integrase Inhibitors Sales by Region
2.4.1 Global Integrase Inhibitors Sales by Region (2017-2022)
2.4.2 Global Sales Integrase Inhibitors by Region (2023-2028)
2.5 Global Integrase Inhibitors Revenue by Region
2.5.1 Global Integrase Inhibitors Revenue by Region (2017-2022)
2.5.2 Global Integrase Inhibitors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Integrase Inhibitors Sales by Manufacturers
3.1.1 Global Top Integrase Inhibitors Manufacturers by Sales (2017-2022)
3.1.2 Global Integrase Inhibitors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Integrase Inhibitors in 2021
3.2 Global Integrase Inhibitors Revenue by Manufacturers
3.2.1 Global Integrase Inhibitors Revenue by Manufacturers (2017-2022)
3.2.2 Global Integrase Inhibitors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Integrase Inhibitors Revenue in 2021
3.3 Global Integrase Inhibitors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Integrase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Integrase Inhibitors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Integrase Inhibitors Sales by Type
4.1.1 Global Integrase Inhibitors Historical Sales by Type (2017-2022)
4.1.2 Global Integrase Inhibitors Forecasted Sales by Type (2023-2028)
4.1.3 Global Integrase Inhibitors Sales Market Share by Type (2017-2028)
4.2 Global Integrase Inhibitors Revenue by Type
4.2.1 Global Integrase Inhibitors Historical Revenue by Type (2017-2022)
4.2.2 Global Integrase Inhibitors Forecasted Revenue by Type (2023-2028)
4.2.3 Global Integrase Inhibitors Revenue Market Share by Type (2017-2028)
4.3 Global Integrase Inhibitors Price by Type
4.3.1 Global Integrase Inhibitors Price by Type (2017-2022)
4.3.2 Global Integrase Inhibitors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Integrase Inhibitors Sales by Application
5.1.1 Global Integrase Inhibitors Historical Sales by Application (2017-2022)
5.1.2 Global Integrase Inhibitors Forecasted Sales by Application (2023-2028)
5.1.3 Global Integrase Inhibitors Sales Market Share by Application (2017-2028)
5.2 Global Integrase Inhibitors Revenue by Application
5.2.1 Global Integrase Inhibitors Historical Revenue by Application (2017-2022)
5.2.2 Global Integrase Inhibitors Forecasted Revenue by Application (2023-2028)
5.2.3 Global Integrase Inhibitors Revenue Market Share by Application (2017-2028)
5.3 Global Integrase Inhibitors Price by Application
5.3.1 Global Integrase Inhibitors Price by Application (2017-2022)
5.3.2 Global Integrase Inhibitors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Integrase Inhibitors Market Size by Type
6.1.1 North America Integrase Inhibitors Sales by Type (2017-2028)
6.1.2 North America Integrase Inhibitors Revenue by Type (2017-2028)
6.2 North America Integrase Inhibitors Market Size by Application
6.2.1 North America Integrase Inhibitors Sales by Application (2017-2028)
6.2.2 North America Integrase Inhibitors Revenue by Application (2017-2028)
6.3 North America Integrase Inhibitors Market Size by Country
6.3.1 North America Integrase Inhibitors Sales by Country (2017-2028)
6.3.2 North America Integrase Inhibitors Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Integrase Inhibitors Market Size by Type
7.1.1 Europe Integrase Inhibitors Sales by Type (2017-2028)
7.1.2 Europe Integrase Inhibitors Revenue by Type (2017-2028)
7.2 Europe Integrase Inhibitors Market Size by Application
7.2.1 Europe Integrase Inhibitors Sales by Application (2017-2028)
7.2.2 Europe Integrase Inhibitors Revenue by Application (2017-2028)
7.3 Europe Integrase Inhibitors Market Size by Country
7.3.1 Europe Integrase Inhibitors Sales by Country (2017-2028)
7.3.2 Europe Integrase Inhibitors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Integrase Inhibitors Market Size by Type
8.1.1 Asia Pacific Integrase Inhibitors Sales by Type (2017-2028)
8.1.2 Asia Pacific Integrase Inhibitors Revenue by Type (2017-2028)
8.2 Asia Pacific Integrase Inhibitors Market Size by Application
8.2.1 Asia Pacific Integrase Inhibitors Sales by Application (2017-2028)
8.2.2 Asia Pacific Integrase Inhibitors Revenue by Application (2017-2028)
8.3 Asia Pacific Integrase Inhibitors Market Size by Region
8.3.1 Asia Pacific Integrase Inhibitors Sales by Region (2017-2028)
8.3.2 Asia Pacific Integrase Inhibitors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Integrase Inhibitors Market Size by Type
9.1.1 Latin America Integrase Inhibitors Sales by Type (2017-2028)
9.1.2 Latin America Integrase Inhibitors Revenue by Type (2017-2028)
9.2 Latin America Integrase Inhibitors Market Size by Application
9.2.1 Latin America Integrase Inhibitors Sales by Application (2017-2028)
9.2.2 Latin America Integrase Inhibitors Revenue by Application (2017-2028)
9.3 Latin America Integrase Inhibitors Market Size by Country
9.3.1 Latin America Integrase Inhibitors Sales by Country (2017-2028)
9.3.2 Latin America Integrase Inhibitors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Integrase Inhibitors Market Size by Type
10.1.1 Middle East and Africa Integrase Inhibitors Sales by Type (2017-2028)
10.1.2 Middle East and Africa Integrase Inhibitors Revenue by Type (2017-2028)
10.2 Middle East and Africa Integrase Inhibitors Market Size by Application
10.2.1 Middle East and Africa Integrase Inhibitors Sales by Application (2017-2028)
10.2.2 Middle East and Africa Integrase Inhibitors Revenue by Application (2017-2028)
10.3 Middle East and Africa Integrase Inhibitors Market Size by Country
10.3.1 Middle East and Africa Integrase Inhibitors Sales by Country (2017-2028)
10.3.2 Middle East and Africa Integrase Inhibitors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Hetero Drugs
11.3.1 Hetero Drugs Corporation Information
11.3.2 Hetero Drugs Overview
11.3.3 Hetero Drugs Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hetero Drugs Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hetero Drugs Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Corporation Information
11.5.2 Aurobindo Pharma Overview
11.5.3 Aurobindo Pharma Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Aurobindo Pharma Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aurobindo Pharma Recent Developments
11.6 Cipla
11.6.1 Cipla Corporation Information
11.6.2 Cipla Overview
11.6.3 Cipla Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cipla Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cipla Recent Developments
11.7 Laurus Labs
11.7.1 Laurus Labs Corporation Information
11.7.2 Laurus Labs Overview
11.7.3 Laurus Labs Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Laurus Labs Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Laurus Labs Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Corporation Information
11.8.2 Gilead Sciences Overview
11.8.3 Gilead Sciences Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Gilead Sciences Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gilead Sciences Recent Developments
11.9 Micro Labs
11.9.1 Micro Labs Corporation Information
11.9.2 Micro Labs Overview
11.9.3 Micro Labs Integrase Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Micro Labs Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Micro Labs Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Integrase Inhibitors Industry Chain Analysis
12.2 Integrase Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Integrase Inhibitors Production Mode & Process
12.4 Integrase Inhibitors Sales and Marketing
12.4.1 Integrase Inhibitors Sales Channels
12.4.2 Integrase Inhibitors Distributors
12.5 Integrase Inhibitors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Integrase Inhibitors Industry Trends
13.2 Integrase Inhibitors Market Drivers
13.3 Integrase Inhibitors Market Challenges
13.4 Integrase Inhibitors Market Restraints
14 Key Findings in The Global Integrase Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Integrase Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Raltegravir
Table 3. Major Manufacturers of Dolutegravir
Table 4. Major Manufacturers of Elvitegravir
Table 5. Major Manufacturers of Bictegravir
Table 6. Global Integrase Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Integrase Inhibitors Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Integrase Inhibitors Sales by Region (2017-2022) & (K Units)
Table 9. Global Integrase Inhibitors Sales Market Share by Region (2017-2022)
Table 10. Global Integrase Inhibitors Sales by Region (2023-2028) & (K Units)
Table 11. Global Integrase Inhibitors Sales Market Share by Region (2023-2028)
Table 12. Global Integrase Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Integrase Inhibitors Revenue Market Share by Region (2017-2022)
Table 14. Global Integrase Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Integrase Inhibitors Revenue Market Share by Region (2023-2028)
Table 16. Global Integrase Inhibitors Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Integrase Inhibitors Sales Share by Manufacturers (2017-2022)
Table 18. Global Integrase Inhibitors Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Integrase Inhibitors Revenue Share by Manufacturers (2017-2022)
Table 20. Integrase Inhibitors Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Integrase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Integrase Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Integrase Inhibitors as of 2021)
Table 23. Integrase Inhibitors Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Integrase Inhibitors Product Offered
Table 25. Date of Manufacturers Enter into Integrase Inhibitors Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Integrase Inhibitors Sales by Type (2017-2022) & (K Units)
Table 28. Global Integrase Inhibitors Sales by Type (2023-2028) & (K Units)
Table 29. Global Integrase Inhibitors Sales Share by Type (2017-2022)
Table 30. Global Integrase Inhibitors Sales Share by Type (2023-2028)
Table 31. Global Integrase Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Integrase Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Integrase Inhibitors Revenue Share by Type (2017-2022)
Table 34. Global Integrase Inhibitors Revenue Share by Type (2023-2028)
Table 35. Integrase Inhibitors Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Integrase Inhibitors Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Integrase Inhibitors Sales by Application (2017-2022) & (K Units)
Table 38. Global Integrase Inhibitors Sales by Application (2023-2028) & (K Units)
Table 39. Global Integrase Inhibitors Sales Share by Application (2017-2022)
Table 40. Global Integrase Inhibitors Sales Share by Application (2023-2028)
Table 41. Global Integrase Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Integrase Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Integrase Inhibitors Revenue Share by Application (2017-2022)
Table 44. Global Integrase Inhibitors Revenue Share by Application (2023-2028)
Table 45. Integrase Inhibitors Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Integrase Inhibitors Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Integrase Inhibitors Sales by Type (2017-2022) & (K Units)
Table 48. North America Integrase Inhibitors Sales by Type (2023-2028) & (K Units)
Table 49. North America Integrase Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Integrase Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Integrase Inhibitors Sales by Application (2017-2022) & (K Units)
Table 52. North America Integrase Inhibitors Sales by Application (2023-2028) & (K Units)
Table 53. North America Integrase Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Integrase Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Integrase Inhibitors Sales by Country (2017-2022) & (K Units)
Table 56. North America Integrase Inhibitors Sales by Country (2023-2028) & (K Units)
Table 57. North America Integrase Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Integrase Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Integrase Inhibitors Sales by Type (2017-2022) & (K Units)
Table 60. Europe Integrase Inhibitors Sales by Type (2023-2028) & (K Units)
Table 61. Europe Integrase Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Integrase Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Integrase Inhibitors Sales by Application (2017-2022) & (K Units)
Table 64. Europe Integrase Inhibitors Sales by Application (2023-2028) & (K Units)
Table 65. Europe Integrase Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Integrase Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Integrase Inhibitors Sales by Country (2017-2022) & (K Units)
Table 68. Europe Integrase Inhibitors Sales by Country (2023-2028) & (K Units)
Table 69. Europe Integrase Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Integrase Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Integrase Inhibitors Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Integrase Inhibitors Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Integrase Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Integrase Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Integrase Inhibitors Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Integrase Inhibitors Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Integrase Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Integrase Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Integrase Inhibitors Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Integrase Inhibitors Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Integrase Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Integrase Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Integrase Inhibitors Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Integrase Inhibitors Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Integrase Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Integrase Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Integrase Inhibitors Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Integrase Inhibitors Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Integrase Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Integrase Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Integrase Inhibitors Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Integrase Inhibitors Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Integrase Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Integrase Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Integrase Inhibitors Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Integrase Inhibitors Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Integrase Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Integrase Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Integrase Inhibitors Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Integrase Inhibitors Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Integrase Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Integrase Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Integrase Inhibitors Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Integrase Inhibitors Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Integrase Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Integrase Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 107. Merck Corporation Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Merck Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. GlaxoSmithKline Corporation Information
Table 113. GlaxoSmithKline Description and Major Businesses
Table 114. GlaxoSmithKline Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. GlaxoSmithKline Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GlaxoSmithKline Recent Developments
Table 117. Hetero Drugs Corporation Information
Table 118. Hetero Drugs Description and Major Businesses
Table 119. Hetero Drugs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Hetero Drugs Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Hetero Drugs Recent Developments
Table 122. Mylan Corporation Information
Table 123. Mylan Description and Major Businesses
Table 124. Mylan Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Mylan Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Recent Developments
Table 127. Aurobindo Pharma Corporation Information
Table 128. Aurobindo Pharma Description and Major Businesses
Table 129. Aurobindo Pharma Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Aurobindo Pharma Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Aurobindo Pharma Recent Developments
Table 132. Cipla Corporation Information
Table 133. Cipla Description and Major Businesses
Table 134. Cipla Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Cipla Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Cipla Recent Developments
Table 137. Laurus Labs Corporation Information
Table 138. Laurus Labs Description and Major Businesses
Table 139. Laurus Labs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Laurus Labs Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Laurus Labs Recent Developments
Table 142. Gilead Sciences Corporation Information
Table 143. Gilead Sciences Description and Major Businesses
Table 144. Gilead Sciences Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Gilead Sciences Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Gilead Sciences Recent Developments
Table 147. Micro Labs Corporation Information
Table 148. Micro Labs Description and Major Businesses
Table 149. Micro Labs Integrase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Micro Labs Integrase Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Micro Labs Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Integrase Inhibitors Distributors List
Table 155. Integrase Inhibitors Customers List
Table 156. Integrase Inhibitors Market Trends
Table 157. Integrase Inhibitors Market Drivers
Table 158. Integrase Inhibitors Market Challenges
Table 159. Integrase Inhibitors Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Integrase Inhibitors Product Picture
Figure 3. Global Integrase Inhibitors Market Share by Type in 2021 & 2028
Figure 3. Raltegravir Product Picture
Figure 4. Dolutegravir Product Picture
Figure 5. Elvitegravir Product Picture
Figure 6. Bictegravir Product Picture
Figure 7. Global Integrase Inhibitors Market Share by Application in 2021 & 2028
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Integrase Inhibitors Report Years Considered
Figure 11. Global Integrase Inhibitors Sales 2017-2028 (K Units)
Figure 12. Global Integrase Inhibitors Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Integrase Inhibitors Revenue 2017-2028 (US$ Million)
Figure 14. Global Integrase Inhibitors Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Integrase Inhibitors Sales Market Share by Region (2017-2022)
Figure 16. Global Integrase Inhibitors Sales Market Share by Region (2023-2028)
Figure 17. North America Integrase Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 18. North America Integrase Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Integrase Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Integrase Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Integrase Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Integrase Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Integrase Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Integrase Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Integrase Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Integrase Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Integrase Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Integrase Inhibitors in the World: Market Share by Integrase Inhibitors Revenue in 2021
Figure 29. Global Integrase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Integrase Inhibitors Sales Market Share by Type (2017-2028)
Figure 31. Global Integrase Inhibitors Revenue Market Share by Type (2017-2028)
Figure 32. Global Integrase Inhibitors Sales Market Share by Application (2017-2028)
Figure 33. Global Integrase Inhibitors Revenue Market Share by Application (2017-2028)
Figure 34. North America Integrase Inhibitors Sales Market Share by Type (2017-2028)
Figure 35. North America Integrase Inhibitors Revenue Market Share by Type (2017-2028)
Figure 36. North America Integrase Inhibitors Sales Market Share by Application (2017-2028)
Figure 37. North America Integrase Inhibitors Revenue Market Share by Application (2017-2028)
Figure 38. North America Integrase Inhibitors Sales Share by Country (2017-2028)
Figure 39. North America Integrase Inhibitors Revenue Share by Country (2017-2028)
Figure 40. United States Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Integrase Inhibitors Sales Market Share by Type (2017-2028)
Figure 43. Europe Integrase Inhibitors Revenue Market Share by Type (2017-2028)
Figure 44. Europe Integrase Inhibitors Sales Market Share by Application (2017-2028)
Figure 45. Europe Integrase Inhibitors Revenue Market Share by Application (2017-2028)
Figure 46. Europe Integrase Inhibitors Sales Share by Country (2017-2028)
Figure 47. Europe Integrase Inhibitors Revenue Share by Country (2017-2028)
Figure 48. Germany Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 49. France Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Integrase Inhibitors Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Integrase Inhibitors Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Integrase Inhibitors Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Integrase Inhibitors Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Integrase Inhibitors Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Integrase Inhibitors Revenue Share by Region (2017-2028)
Figure 59. China Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 62. India Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Integrase Inhibitors Sales Market Share by Type (2017-2028)
Figure 69. Latin America Integrase Inhibitors Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Integrase Inhibitors Sales Market Share by Application (2017-2028)
Figure 71. Latin America Integrase Inhibitors Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Integrase Inhibitors Sales Share by Country (2017-2028)
Figure 73. Latin America Integrase Inhibitors Revenue Share by Country (2017-2028)
Figure 74. Mexico Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Integrase Inhibitors Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Integrase Inhibitors Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Integrase Inhibitors Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Integrase Inhibitors Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Integrase Inhibitors Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Integrase Inhibitors Revenue Share by Country (2017-2028)
Figure 83. Turkey Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Integrase Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 86. Integrase Inhibitors Value Chain
Figure 87. Integrase Inhibitors Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---